Improved muscle function in a phase I/II clinical trial of albuterol in Pompe disease. [electronic resource]
Producer: 20201112Description: 67-72 p. digitalISSN:- 1096-7206
- Adult
- Albuterol -- administration & dosage
- Double-Blind Method
- Enzyme Replacement Therapy
- Female
- Forced Expiratory Volume
- Glycogen Storage Disease Type II -- drug therapy
- Humans
- Late Onset Disorders -- drug therapy
- Male
- Middle Aged
- Muscle, Skeletal -- drug effects
- Treatment Outcome
- Vital Capacity
- Walk Test
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.